The IMF’s Understanding series of cancer information booklets is designed to acquaint you with specific multiple myeloma-related tests, treatments and therapies, supportive care measures, and common adverse events.
Due to current health and safety precautions, hard copy mailing of IMF publications are temporarily delayed up to several weeks. However, digital versions of all IMF publications are available below.
Full of our informative publications, including our Patient Handbook and selections from the popular Understanding Series, the Info Pack will…
Blenrep (belantamab mafodotin-blmf) is an antibody-drug conjugate (ADC), the first in a new class of treatments for myeloma. Blenrep is the…
We Thank Our Sponsors:
Amgen, GSK, Janssen, Karyopharm Therapeutics, Oncopeptides, Inc. and Takeda